Lameditech Announces First Zero-Interest Convertible Bond Issuance Worth 8.3 Billion Won
Lameditech has announced the issuance of its first convertible bond (CB) worth 8.3 billion won, as disclosed on the 7th. This issuance involves a total of 83 billion won and features a 0% coupon rate and a 0% maturity interest rate, reflecting conditions based on investor trust. The maturity date for the bonds is set for November 17, 2030, with a conversion price of 7,043 won per share.
The funds raised through this issuance are aimed at driving growth in overseas sales. Approximately 60 billion won of the total amount will be allocated towards expanding global sales, particularly in North and South America, as well as establishing local distribution channels. The remaining 23 billion won will be invested in enhancing production capacity and capital expenditures (CAPEX).
A representative from Lameditech stated, "This convertible bond issuance is a strategic investment aimed at significantly expanding our sales in the global market. We will strengthen our sales activities focused on North and South America and bolster our production systems to respond to the growing global demand."
The bonds will be issued to private equity funds managed by major domestic asset management companies, with an estimated 1,178,000 shares to be issued upon conversion, accounting for about 13.4% of the total number of shares currently issued.
Lameditech specializes in medical and beauty devices based on miniaturized laser technology, holding a competitive portfolio of compact laser medical devices and beauty devices in the global market.
The funds raised through this issuance are aimed at driving growth in overseas sales. Approximately 60 billion won of the total amount will be allocated towards expanding global sales, particularly in North and South America, as well as establishing local distribution channels. The remaining 23 billion won will be invested in enhancing production capacity and capital expenditures (CAPEX).
A representative from Lameditech stated, "This convertible bond issuance is a strategic investment aimed at significantly expanding our sales in the global market. We will strengthen our sales activities focused on North and South America and bolster our production systems to respond to the growing global demand."
The bonds will be issued to private equity funds managed by major domestic asset management companies, with an estimated 1,178,000 shares to be issued upon conversion, accounting for about 13.4% of the total number of shares currently issued.
Lameditech specializes in medical and beauty devices based on miniaturized laser technology, holding a competitive portfolio of compact laser medical devices and beauty devices in the global market.
Like
0
Upvote0
- PrevTimothée Chalamet Sparks Controversy with Comments on Parenting and Existence
- NextThe Rise and Fall of Kakaos Founder: A Reflection on Success and Societal Perception
No comments yet.